November 2020 Price Concessions 1st Update

THIS CONTENT HAS NOW EXPIRED
November 2020 Price Concessions 1st Update
November 17, 2020
The Department of Health and Social Care (DHSC) has today granted the following initial list of price concessions:
Drug | Pack Size | Price Concession |
Ciprofloxacin 250mg tablets | 10 | £1.95 |
Ciprofloxacin 500mg tablets | 10 | £5.52 |
Duloxetine 20mg gastro-resistant capsules | 28 | £9.98 |
Duloxetine 30mg gastro-resistant capsules | 28 | £2.37 |
Duloxetine 60mg gastro-resistant capsules | 28 | £4.56 |
Enalapril 10mg tablets | 28 | £4.99 |
Enalapril 20mg tablets | 28 | £10.20 |
Esomeprazole 20mg gastro-resistant tablets | 28 | £3.99 |
Hydrocortisone 2.5% cream | 15g | £44.00 |
Irbesartan 300mg / Hydrochlorothiazide 12.5mg tablets | 28 | £14.31 |
Lamotrigine 100mg tablets | 56 | £6.18 |
Lamotrigine 50mg tablets | 56 | £4.80 |
Moxonidine 200microgram tablets | 28 | £9.10 |
Moxonidine 300microgram tablets | 28 | £10.50 |
Moxonidine 400microgram tablets | 28 | £8.16 |
Olanzapine 15mg tablets | 28 | £4.20 |
Olanzapine 20mg tablets | 28 | £4.97 |
Oxytetracycline 250mg tablets | 28 | £8.31 |
Rasagiline 1mg tablets | 28 | £10.05 |
No additional endorsements are required for price concessions. A price concession only applies for the month in which it is granted.
PSNC is still working with the DHSC to agree further concessionary prices on other drugs reported to be unavailable at the stated November 2020 Drug Tariff price. Please note that PSNC cannot provide details of any generic products awaiting price concession approval from DHSC.
If you have problems obtaining a Part VIII product at the stated Drug Tariff price, please report the issue using the online feedback form on the PSNC website. Please include full details of the supplier and price paid for any products sourced above the Drug Tariff price. PSNC will investigate the extent of the problem and, if appropriate, discuss the issue with DHSC.
Contractors will be alerted to further updates to the price concession list through our website and via our e-news email. If you wish to subscribe to our email list, you can receive an email as soon as any announcements are made.
Posted in: Dispensing & Supply, Headline